Skip to main content
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED logo

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED — Investor Relations & Filings

Ticker · MVP ISIN · AU000000MVP2 LEI · 9845007EAECAOD1U4493 ASX Manufacturing
Open in API
Filings indexed 908 across all filing types
Latest filing 2024-08-05 Capital/Financing Update
Country AU Australia
Listing ASX MVP

About MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

https://medicaldev.com

Medical Developments International Limited specializes in the development and distribution of emergency pain relief and respiratory products. The company's flagship product is Penthrox, a handheld, self-administered inhaler providing rapid-onset, non-opioid analgesia using methoxyflurane. Penthrox is utilized globally by emergency medical services, hospitals, and for procedural pain in various clinical settings. Additionally, the company manufactures a range of respiratory medical devices, including anti-static spacers and asthma management tools designed to optimize medication delivery. The organization focuses on providing portable, effective solutions for acute pain management and respiratory care, catering to healthcare professionals and patients in emergency, surgical, and primary care environments.

Recent filings

Filing Released Lang Actions
Cleansing Notice 1 page 160.4KB
Capital/Financing Update Classification · 95% confidence The document is a 'Cleansing Notice' related to an institutional placement of shares by Medical Developments International Limited. It references compliance with sections of the Corporations Act and provides details about the issuance of shares to sophisticated and institutional investors. The document is short (1671 characters) and serves as a regulatory announcement about a capital raising event rather than a detailed financial report or presentation. It does not contain financial statements or detailed analysis, nor is it a full report or earnings release. This fits the category of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2024-08-05 English
Application for quotation of securities - MVP 7 pages 20.9KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and contains detailed information about securities to be quoted on the ASX, including issue dates, number of securities, issue prices, and distribution schedules. It references previous announcements such as Appendix 3B related to securities issuance. The document is an official application for the quotation of securities following a capital raising or placement transaction. This type of filing corresponds to announcements related to new share issues or capital changes. Therefore, the document fits the category of Share Issue/Capital Change (SHA). The document length is 6486 characters, which is sufficient to contain substantive details rather than just a brief announcement or a report publication notice.
2024-08-04 English
Cleansing Notice 1 page 222.1KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Cleansing Notice - 2024 Institutional Placement and Institutional Entitlement' and discusses the issuance of new shares to institutional investors. It references compliance with sections of the Corporations Act related to disclosure exemptions for share placements. The content focuses on the announcement of a share issuance event and legal compliance notices rather than detailed financial data or report content. The document length is short (1708 characters), and it is clearly an announcement related to capital raising activities. Therefore, it fits best under the category 'Capital/Financing Update' (CAP).
2024-08-04 English
MVP Retail Entitlement Offer Booklet 72 pages 6.8MB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 2 August 2024 regarding the dispatch of a Retail Offer Booklet for a pro-rata accelerated non-renounceable entitlement offer of new shares by Medical Developments International Ltd. It details the terms of the Retail Entitlement Offer, including the offer price, record date, and instructions for shareholders. The document is primarily an announcement about a capital raising event and the dispatch of offer materials to shareholders. It does not contain financial statements or detailed financial analysis but focuses on the capital raising process and shareholder instructions. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed offer information, consistent with a capital raising announcement rather than a brief notice or regulatory filing.
2024-08-01 English
MVP Letter to ineligible shareholders 2 pages 128.4KB
Capital/Financing Update Classification · 95% confidence The document is a letter dated 2 August 2024 from Medical Developments International Limited to shareholders informing them about an accelerated non-renounceable entitlement offer. It details the terms of the offer, eligibility criteria, and the fact that certain shareholders are ineligible to participate. The letter references the offer booklet to be lodged with the ASX and available on the company's website, indicating this document is a notification or announcement related to a capital raising event. It does not contain financial statements or detailed financial data but rather communicates the terms and eligibility of the entitlement offer. This fits the category of a Capital/Financing Update (CAP) as it provides updates on the company's fundraising activities and capital structure changes.
2024-08-01 English
Retail Entitlement Offer Investor Call Details 1 pa
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 2 August 2024 about a Retail Entitlement Offer Investor Call scheduled for 6 August 2024. It mentions dispatching the Retail Offer Booklet to eligible shareholders and provides details for an investor briefing with CEO and CFO, including a registration link and Q&A opportunity. The document is short (1659 characters) and serves as an announcement for an upcoming investor call related to a capital raising event (entitlement offer). There is no financial data or detailed report content, only an invitation and information about the call. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2024-08-01 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.